Free Trial

Inozyme Pharma (INZY) Insider Trading & Ownership

→ Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad)
Free INZY Stock Alerts
$4.65
+0.05 (+1.09%)
(As of 02:45 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Inozyme Pharma (NASDAQ:INZY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.88%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$5.42 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$52,209.62
Get INZY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inozyme Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INZY Insider Buying and Selling by Quarter

Ad Behind the Markets
The Weight Loss Pill That Could Disrupt a $32 Billion Industry
A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.
Don't miss out on the "next Ozempic" >>>

Inozyme Pharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024Douglas A TrecoCEOSell7,523$6.94$52,209.62  
8/1/2023Pivotal Bioventure Partners FuDirectorBuy833,333$4.80$3,999,998.40  
5/11/2023Robert Lorne HopfnerDirectorBuy219,230$6.48$1,420,610.40  
(Data available from 1/1/2013 forward)

INZY Insider Trading Activity - Frequently Asked Questions

Who is on Inozyme Pharma's Insider Roster?

The list of insiders at Inozyme Pharma includes Axel Bolte, Douglas A Treco, Henric Bjorn Bjarke, Longitude Capital Partners Iii, Pivotal Bioventure Partners Fu, and Robert Lorne Hopfner. Learn more on insiders at INZY.

What percentage of Inozyme Pharma stock is owned by insiders?

11.88% of Inozyme Pharma stock is owned by insiders. Learn more on INZY's insider holdings.

Which Inozyme Pharma insiders have been buying company stock?

The following insiders have purchased INZY shares in the last 24 months: Henric Bjorn Bjarke ($29,885.00), Pivotal Bioventure Partners Fu ($3,999,998.40), and Robert Lorne Hopfner ($3,174,031.88).

How much insider buying is happening at Inozyme Pharma?

Insiders have purchased a total of 1,469,729 INZY shares in the last 24 months for a total of $7,203,915.28 bought.

Which Inozyme Pharma insiders have been selling company stock?

The following insider sold INZY shares in the last 24 months: Douglas A Treco ($52,209.62).

How much insider selling is happening at Inozyme Pharma?

Insiders have sold a total of 7,523 Inozyme Pharma shares in the last 24 months for a total of $52,209.62 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:INZY) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners
The Department of Defense Has a New Drone Contractor
The Tomorrow Investor
AI “wealth window” is closing June 25th
Paradigm Press
Elon Musk Secret Crypto Plot Exposed
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The #1 lithium battery stock to have on your radar in 2024!
Smallcaps Daily
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
[URGENT] DO NOT Touch These AI Stocks!
Weiss Ratings
Charles Payne Demystifies Options
Unstoppable Prosperity